Document Classification

Section Type: RESULTS

Text: After multivariable adjustment, among patients treated with rosiglitazone, mortality was similar (hazard ratio [HR], 0. 83 ; 95 % confidence interval [CI], 0. 58-1. 18), whereas there was a lower incidence of composite death, myocardial infarction, and stroke (HR, 0. 72 ; 95 % CI, 0. 55-0. 93) and stroke (HR, 0. 36 ; 95 % CI, 0. 16-0. 86) and a higher incidence of fractures (HR, 1. 62 ; 95 % CI, 1. 05-2. 51) ; the incidence of myocardial infarction (HR, 0. 77 ; 95 % CI, 0. 54-1. 10) and congestive heart failure (HR, 1. 22 ; 95 % CI, 0. 84-1. 82) did not differ significantly.